Genetic Test for Breast Cancer Screening Cost-Effective for Women at Intermediate RiskEileen KoutnikFotopoulos
This may be a relief. However, there is also the frustrating fact that even if a woman has a negative genetic test, she is still at higher risk for breast cancer than the general population due to the risk factor of having multiple family members with breast cancer. Another possibility with...
Psychosocial and clinical factors associated with family communication of cancer genetic test results among women diagnosed with breast cancer at a young age. J Genet Couns. 2017;26(1):173-181. doi:10.1007/s10897-016-9995-0Crossref See More About Oncology Breast Cancer Women's Health ...
Objectives: Genetic mutations in breast cancer susceptibility genes BRCA1/2 are associated with an increased risk of breast/ovarian cancers. Cost-effective preventive measures are available for women who test positive. The objective of this study was to determine at what risk of mutation it is cos...
Two separate dependent variables were used as measures for intention to obtain BRCA testing: (1) "I plan to have a genetic test for breast cancer only if my insurance covers the cost"; and (2) "I plan to have a genetic test for breast cancer, even if I have to pay for it myself...
To evaluate the cost-effectiveness of BRCA testing in women with breast cancer, and cascade testing in family members of BRCA mutation carriers. A cost-effectiveness analysis was conducted using a cohort Markov model from a health-payer perspective. The
To examine the relative cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer provided by Genetic Services of Western Australia. The relative cost-effectiveness was assessed using a decision analytic model. The cost and outcomes of genetic testing was compared in first-...
Targeted genetic testing is a tool to identify women at increased risk of gynaecological cancer.Objective: This systematic review evaluates the results and quality of cost-effectiveness modeling studies that assessedtargeted genetic-based screen-and-treat strategies to prevent breast and ovarian cancer.Met...
The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.
Background Genetic analysis for individuals who are at risk for hereditary breast and ovarian cancer syndrome (HBOC) has becoming widely accepted. The poor introduction of the genetic testing of BRCA in Japan compared with western countries could be due to insufficient recognition of its importance,...